2011 Liz Tilberis Grant Recipient – Ann Klopp
MD Anderson Cancer Center
Fat Cells May Be Source of Stem Cells That Promote Ovarian Cancer
Obesity increases the risk of ovarian cancer, which some evidence suggests may be due to chemicals, such as estrogen, secreted by fat tissue into the blood. Dr. Klopp, however, believes fat cells directly affect tumor growth because they contain stem cells, or self-renewing cells, which can migrate into nearby tumors and support the tumor cells’ growth. Recently, Dr. Klopp isolated stem cells from human omentum, the fatty tissue to which ovarian cancers often metastasize, and in preliminary studies showed these stem cells support the growth and invasion of ovarian cancer cells. In this study, Dr. Klopp will determine if these stem cells migrate into ovarian tumors and increase tumor growth in mice implanted with human ovarian cancer cells. She also will isolate more stem cells from the omentum of patients and determine if these cells help proliferate and spread tumors. Finally, she aims to identify the aberrant molecular pathways that cause the tumor promoting effects in these stem cells. Her findings should increase understanding of obesity’s role as an ovarian cancer risk factor, shed light on why tumors metastasize to the omentum and lead to possible drugs that could block stem cells’ effects on tumor growth and spread.
Ann Klopp, M.D., Ph.D. is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the Department of Radiation Oncology. She is a physician-scientist specializing in the treatment of gynecologic cancers with time dedicated to translational laboratory research. She received her undergraduate degree in Microbiology from the University of Michigan, Ann Arbor. She went on to receive her Ph.D. in Molecular Biology and M.D. from the Medical College of Wisconsin in Milwaukee. She subsequently came to MD Anderson for residency in the Department of Radiation Oncology where she did post-doctoral research investigating the role of bone marrow derived mesenchymal stem cells in the tumor microenvironment. She has received awards for her research including the National AAWR Eleanor Montague Distinguished Resident Award in Radiation Oncology and the Roentgen Award from RSNA for Resident Research. Currently, her laboratory research is focused on understanding effects of adipose and bone-marrow derived stem cells in ovarian and endometrial cancers with a long-term goal career goal of developing new treatments for gynecologic cancers targeting the tumor promoting effects of normal tissue stem cells.
The five-year survival rate for ovarian cancer has increased by only 8% in the last 30 years.
We are at a critical crossroads for supporting research into unlocking the mysteries of ovarian cancer. You can make a difference by supporting the research of the Ovarian Cancer Research Fund.
Help us find a cure for ovarian cancer. Donate online and make a difference.